检索结果 - Jonatan Barrera‐Chimal

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
    Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets

    Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets 由 Jonatan Barrera‐Chimal, Frédéric Jaisser

    出版 2020
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis

    Mineralocorticoid receptor antagonists and kidney diseases: pathophysiological basis 由 Jonatan Barrera‐Chimal, Sophie Girerd, Frédéric Jaisser

    出版 2019
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease

    Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease 由 Toshifumi Nakamura, Sophie Girerd, Frédéric Jaisser, Jonatan Barrera‐Chimal

    出版 2022
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    #1144 Role of PPAR-alpha in folic acid-induced tubulointerstitial fibrosis

    #1144 Role of PPAR-alpha in folic acid-induced tubulointerstitial fibrosis 由 Gabriel Rufino Estrela, Adriano Cleis Arruda, Jonatan Barrera‐Chimal, Ronaldo C. Araújo

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteristics

    Differentiation between emerging non-steroidal and established steroidal mineralocorticoid receptor antagonists: head-to-head comparisons of pharmacological and clinical characteri... 由 Jonatan Barrera‐Chimal, Peter Kolkhof, Ixchel Lima‐Posada, Joachim Alexandre, Patrick Rossignol, Frédéric Jaisser

    出版 2021
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia

    Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia 由 Jonatan Barrera‐Chimal, Sonia Prince, Fouad Fadel, Soumaya El Moghrabi, David G. Warnock, Peter Kolkhof, Frédéric Jaisser

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Kinin B1 Receptor Antagonism Prevents Acute Kidney Injury to Chronic Kidney Disease Transition in Renal Ischemia-Reperfusion by Increasing the M2 Macrophages Population in C57BL6J Mice

    Kinin B1 Receptor Antagonism Prevents Acute Kidney Injury to Chronic Kidney Disease Transition in Renal Ischemia-Reperfusion by Increasing the M2 Macrophages Population in C57BL6J... 由 Gabriel Rufino Estrela, Raisa Brito Santos, Alexandre Budu, Adriano Cleis Arruda, Jonatan Barrera‐Chimal, Ronaldo C. Araújo

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury

    Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury 由 Jonatan Barrera‐Chimal, Rosalba Pérez‐Villalva, Roxana Rodríguez‐Romo, Juan Carlos García Reyna, Norma Uribe, Gerardo Gamba, Norma A. Bobadilla

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Hsp72 is an early and sensitive biomarker to detect acute kidney injury

    Hsp72 is an early and sensitive biomarker to detect acute kidney injury 由 Jonatan Barrera‐Chimal, Rosalba Pérez‐Villalva, Cesar Cortés‐González, Marcos Ojeda‐Cervantes, Gerardo Gamba, Luis E. Morales‐Buenrostro, Norma A. Bobadilla

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2

    PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2 由 Leandro Ceotto Freitas‐Lima, Alexandre Budu, Adriano Cleis Arruda, Mauro Sérgio Perilhão, Jonatan Barrera‐Chimal, Ronaldo C. Araújo, Gabriel Rufino Estrela

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Renal fibrosis due to multiple cisplatin treatment is exacerbated by kinin B1 receptor antagonism

    Renal fibrosis due to multiple cisplatin treatment is exacerbated by kinin B1 receptor antagonism 由 Alexandre Budu, Leandro Ceotto Freitas‐Lima, Adriano Cleis Arruda, Mauro Sérgio Perilhão, Jonatan Barrera‐Chimal, Ronaldo C. Araújo, Gabriel Rufino Estrela

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Recovery from ischemic acute kidney injury by spironolactone administration

    Recovery from ischemic acute kidney injury by spironolactone administration 由 Katy Sánchez-Pozos, Jonatan Barrera‐Chimal, Juan Garzon-Muvdi, Rosalba Pérez‐Villalva, Roxana Rodríguez‐Romo, Cristino Cruz, Gerardo Gamba, Norma A. Bobadilla

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Chronic Kidney Disease Induced by Cisplatin, Folic Acid and Renal Ischemia Reperfusion Induces Anemia and Promotes GATA-2 Activation in Mice

    Chronic Kidney Disease Induced by Cisplatin, Folic Acid and Renal Ischemia Reperfusion Induces Anemia and Promotes GATA-2 Activation in Mice 由 Gabriel Rufino Estrela, Leandro Ceotto Freitas‐Lima, Alexandre Budu, Adriano Cleis Arruda, Mauro Sérgio Perilhão, Ricardo Ambrósio Fock, Jonatan Barrera‐Chimal, Ronaldo C. Araújo

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury–Mediated Chronic Kidney Disease

    Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury–Mediated Chronic Kidney Disease 由 Lionel Lattenist, Sebastian M. Lechner, Smail Messaoudi, Alan Le Mercier, Soumaya El Moghrabi, Sonia Prince, Norma A. Bobadilla, Peter Kolkhof, Frédéric Jaisser, Jonatan Barrera‐Chimal

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1

    Benefit of Mineralocorticoid Receptor Antagonism in AKI: Role of Vascular Smooth Muscle Rac1 由 Jonatan Barrera‐Chimal, Gwennan André‐Grégoire, Aurélie Nguyen Dinh Cat, Sebastian M. Lechner, Jérôme Cau, Sonia Prince, Peter Kolkhof, Gervaise Loirand, Vincent Sauzeau, Thierry Hauet, Frédéric Jaisser

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease

    AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease 由 Roxana Rodríguez‐Romo, Kenia Benítez, Jonatan Barrera‐Chimal, Rosalba Pérez‐Villalva, Arturo Gómez, Diana Aguilar‐León, Jesus Rangel-Santiago, Sara Huerta, Gerardo Gamba, Norma Uribe, Norma A. Bobadilla

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Physical Exercise Exacerbates Acute Kidney Injury Induced by LPS via Toll-Like Receptor 4

    Physical Exercise Exacerbates Acute Kidney Injury Induced by LPS via Toll-Like Receptor 4 由 Talita Guerreiro Rodrigues Húngaro, Leandro Ceotto Freitas‐Lima, Marcos Fernandes Gregnani, Mauro Sérgio Perilhão, Thaís Alves-Silva, Adriano Cleis Arruda, Jonatan Barrera‐Chimal, Gabriel Rufino Estrela, Ronaldo C. Araújo

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway

    The Calcium-Sensing Receptor Increases Activity of the Renal NCC through the WNK4-SPAK Pathway 由 Silvana Bazúa‐Valenti, Lorena Rojas‐Vega, María Castañeda‐Bueno, Jonatan Barrera‐Chimal, Rocí­o Bautista, Luz Graciela Cervantes-Pérez, Norma Vázquez, Consuelo Plata, Adrián Rafael Murillo‐de‐Ozores, Lorenza González‐Mariscal, David H. Ellison, Daniela Riccardi, Norma A. Bobadilla, Gerardo Gamba

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: